Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 27 December 2025
- Conf. stmt due
- 17 December 2026
- Last conf. stmt
- 3 December 2025
Charles River Laboratories Holdings Limited
- Incorporated
- 10 December 1999 (26 years)
- Industry
- Non-trading company (74990)
- Directors
- Rushna Heneghan
- Owned by
- Charles River Nederland BV
- Accounts type
- Full
- Region
- South East
- Address
- Manston RoadMargateKentCT9 4LT
Officers 4 active
Officer details are public data from the Companies House register.
American
Born May 1976 (50)
Heneghan, Rushna
Secretary · Appointed 1 January 2021
Heneghan, Rushna
Director · Appointed 1 January 2021
American
Born June 1963 (63)
British
Born November 1967
Officer history (15 former)
29 September 2025
29 September 2025
6 June 2022
6 June 2022
1 January 2021
Appointed Heneghan, Rushna as Secretary
1 January 2021
Appointed Heneghan, Rushna as Director
31 December 2020
31 December 2020
Resigned Price, Sarah Margaret as Secretary
20 May 2020
20 May 2020
23 December 2019
Appointed Price, Sarah Margaret as Secretary
22 December 2019
1 September 2015
1 September 2015
31 August 2015
31 August 2015
31 January 2008
31 January 2008
12 March 2007
12 March 2007
12 March 2007
25 April 2005
Resigned Shaughnessy, Dennis Robert as Director
1 January 2001
31 December 2000
31 December 2000
18 February 2000
18 February 2000
10 December 1999
10 December 1999
10 December 1999
10 December 1999
10 December 1999
10 December 1999
Appointed Shaughnessy, Dennis Robert as Director
10 December 1999
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Charles River Nederland BV
Corporate entity · Notified 12 September 2019
Owns 75–100% of shares
Limited Company
Group structure 6 companies
Ownership group derived from the Companies House PSC register
Charles River Laboratories Holdings Limited This company
Biofocus Dpi (Holdings) Ltd Owns 75–100% of shares
Charles River Laboratories England Limited Owns 75–100% of shares
Iqvia Laboratories Discovery UK Ltd Owns 75–100% of shares
Celsis Group Limited Owns 75–100% of shares
Financials
Balance sheet as at 27 December 2025 · full accounts
- Net Assets
- £226,239,000
- Profit Before Tax
- £6,895,000
- Debt Ratio
- 0%
- Current Ratio
- 303.7x
- Return on Equity
- 3%
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | |
|---|---|---|
| Fixed Assets | £221,093,000 | £221,093,000 |
| Current Assets | £5,163,000 | £15,400,000 |
| Creditors (< 1 year) | £17,000 | £16,000 |
| Creditors (> 1 year) | £0 | £0 |
| Net Current Assets | £5,146,000 | £15,384,000 |
| Net Assets | £226,239,000 | £236,477,000 |
| Shareholder Funds | £226,239,000 | £236,477,000 |
Filings 121
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 30 June 2026 | Full accounts | 27 December 2025 | ||
| 24 December 2025 | Confirmation statement with updates | 3 December 2025 | ||
| 22 December 2025 | Replacement filing for the appointment of a director | |||
| 6 October 2025 | Appointment of a director | |||
| 3 October 2025 | Termination of appointment of a director |
Some other companies at this address
Other companies in this industry
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →